Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin

OBJECTIVE: Deterioration in ventricular function is often observed in patients treated with anthracyclines for cancer. There is a paucity of evidence on interventions that might provide cardio-protection. We investigated whether prophylactic use of carvedilol can prevent doxorubicin-induced cardioto...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Indian Heart J
Glavni autori: Abuosa, Ahmed Mohamed, Elshiekh, Ayman Hassan, Qureshi, Kahekashan, Abrar, Mohammed Burhan, Kholeif, Mona A., Kinsara, Abdulhalim Jamal, Andejani, Abdulwahab, Ahmed, Adel H., Cleland, John G.F.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2018
Teme:
Clinical and Preventive Cardiology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6310701/
https://ncbi.nlm.nih.gov/pubmed/30595329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2018.06.011
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items